Cargando…

Protein Interactome of Muscle Invasive Bladder Cancer

Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alterations of several molecular pathways that result in heterogeneous phenotypes and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhat, Akshay, Heinzel, Andreas, Mayer, Bernd, Perco, Paul, Mühlberger, Irmgard, Husi, Holger, Merseburger, Axel S., Zoidakis, Jerome, Vlahou, Antonia, Schanstra, Joost P., Mischak, Harald, Jankowski, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287622/ https://www.ncbi.nlm.nih.gov/pubmed/25569276 http://dx.doi.org/10.1371/journal.pone.0116404

Ejemplares similares

BcCluster: A Bladder Cancer Database at the Molecular Level
por: Bhat, Akshay, et al.
Publicado: (2016)

PeptiCKDdb—peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease
por: Krochmal, Magdalena, et al.
Publicado: (2016)

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of –omics findings
por: Latosinska, Agnieszka, et al.
Publicado: (2016)

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis
por: Latosinska, Agnieszka, et al.
Publicado: (2015)

Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD
por: Lohia, Sonnal, et al.
Publicado: (2023)

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
por: Lygirou, Vasiliki, et al.
Publicado: (2018)

Collagen-Derived Peptides in CKD: A Link to Fibrosis
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018)

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019)

Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney Disease
por: Tserga, Aggeliki, et al.
Publicado: (2022)

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine
por: Filip, Szymon, et al.
Publicado: (2015)

Identification of ageing-associated naturally occurring peptides in human urine
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2015)

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer
por: Frantzi, Maria, et al.
Publicado: (2020)

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios
por: Keller, Felix, et al.
Publicado: (2023)

A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI
por: Husi, Holger, et al.
Publicado: (2013)

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
por: Latosinska, Agnieszka, et al.
Publicado: (2017)

Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles
por: Siwy, Justyna, et al.
Publicado: (2012)

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation
por: Latosinska, Agnieszka, et al.
Publicado: (2020)

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation
por: Chatziharalambous, Despina, et al.
Publicado: (2016)

Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease
por: Mokou, Marika, et al.
Publicado: (2019)

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment
por: Lohia, Sonnal, et al.
Publicado: (2023)

Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
por: Lohia, Sonnal, et al.
Publicado: (2022)

Integrative Bioinformatics Analysis of Proteins Associated with the Cardiorenal Syndrome
por: Mühlberger, Irmgard, et al.
Publicado: (2010)

Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers
por: Dakna, Mohammed, et al.
Publicado: (2010)

Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature
por: Stroggilos, Rafael, et al.
Publicado: (2022)

Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
por: He, Tianlin, et al.
Publicado: (2020)

Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma
por: Makridakis, Manousos, et al.
Publicado: (2020)

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
por: Koss, Michael Janusz, et al.
Publicado: (2014)

A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases
por: Neuwirt, Hannes, et al.
Publicado: (2014)

Urine peptidome analysis in cardiorenal syndrome reflects molecular processes
por: Petra, Eleni, et al.
Publicado: (2021)

Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2022)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018)

Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure
por: He, Tianlin, et al.
Publicado: (2021)

Reviewing the Regulators of COL1A1
por: Devos, Hanne, et al.
Publicado: (2023)

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca(2+) signaling in T24M-based bladder cancer models
por: Frantzi, Maria, et al.
Publicado: (2016)

From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action
por: Heinzel, Andreas, et al.
Publicado: (2014)

Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer
por: Andorfer, Peter, et al.
Publicado: (2016)

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination
por: Frantzi, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k7jc8789ipc6quqd04lj6ipaqo